1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Arterial components around the distal ICA on the affected side in patients with and without PHACE syndromea
PHACE (+) (n = 11) PHACE (−) (n = 9) P Valueb A1 Dysplasia = 8 (72.7%) Dysplasia = 7 (77.8%) 1.000 M1 Dysplasia = 0 (0.0%) Dysplasia = 2 (22.2%) .189 OA Ectopic = 1 (9.1%) Ectopic = 4 (44.4%) .127 AchoA Dysplasia = 3 (27.3%) Dysplasia = 2 (22.2%) 1.000 PcomA Dysplasia = 7 (63.6%) Dysplasia = 7 (77.8%) .642 Midbrain Dysplasia = 5 (45.5%) Dysplasia = 4 (44.4%) 1.000